‘Be Selective Buyers’ of Biotech, Raymond James Says
September 01, 2015 at 11:52 AM EDT
Raymond James is staying bullish on biotech. But analyst Christopher Raymond does urge some caution in a note published today launching coverage on a group of 10 stocks that include Biogen (BIIB), Celgene (CELG), and Amgen (AMGN). …we think the path of least resistance in biotech – even in light of last week’s broader market […]